Sökning: "small molecule screening"
Visar resultat 1 - 5 av 59 avhandlingar innehållade orden small molecule screening.
1. Human adenoviruses : new bioassays for antiviral screening and CD46 interaction
Sammanfattning : Adenoviruses are common pathogens all over the world. The majority of the population has at some point been infected with an adenovirus. Although severe disease can occur in otherwise healthy individuals an adenovirus infection is most commonly self limited in these cases. LÄS MER
2. Modeling normal and malignant hematopoiesis in vitro. To screen for extrinsic regulators and differentiation therapy
Sammanfattning : The incredible thing with blood stem cells, also known as hematopoietic stem cells (HSC), is that they can restore normal hematopoiesis in patients that need a new blood system. Since a prerequisite for successful transplantation is immune compatibility, it requires large donor registries to find a suitable match for a recipient. LÄS MER
3. Chemical attenuation of bacterial virulence : small molecule inhibitors of type III secretion
Sammanfattning : Despite the large arsenal of antibiotics available on the market, treatment of bacterial infections becomes more challenging in view of the fact that microbes develop resistance against existing drugs. There is an obvious need for novel drugs acting on both old and new targets in bacteria. LÄS MER
4. Structure-Based Virtual Screening : New Methods and Applications in Infectious Diseases
Sammanfattning : A drug discovery project typically starts with a pharmacological hypothesis: that the modulation of a specific molecular biological mechanism would be beneficial in the treatment of the targeted disease. In a small-molecule project, the next step is to identify hits, i.e. molecules that can effect this modulation. LÄS MER
5. Investigating polymorphism in small molecules using three-dimensional electron diffraction
Sammanfattning : For scientific, regulatory and intellectual property reasons, the discovery and characterisation of polymorphic systems is an integral aspect of the development process of any solid-formulated drug product. Yet, these studies are often hindered by crystal quality and size, poor yields and the generation of mixtures of phases. LÄS MER